We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Redox Potential Used as a Feasible Marker for Banked Blood Quality

By LabMedica International staff writers
Posted on 09 Sep 2021
Print article
Image: The Princeton Applied Research ParstatMC multi-potentiostat was used to identify redox potential as a feasible marker for banked blood quality (Photo courtesy of Ametek)
Image: The Princeton Applied Research ParstatMC multi-potentiostat was used to identify redox potential as a feasible marker for banked blood quality (Photo courtesy of Ametek)
Stored red blood cells (RBCs) may undergo oxidative stress over time, with functional changes affecting oxygen delivery. Central to these changes are oxidation-reduction (redox) reactions and redox potential (RP) that must be maintained for cell function.

Despite the seeming importance and implications of utilizing RP measures, there are currently few means by which to make the measurement directly, and most investigators have relied historically on isolated redox species and secondary markers of oxidative stress such as glutathione couples, malondialdehyde, and estimates of oxidative injury in processed samples.

Biomedical Engineers at the University of Michigan (Ann Arbor, MI, USA) investigated changes in RP over time in banked RBCs, and among RBCs of similar age. The scientists tested multiple random RBC segments from RBC units were tested (n = 32), ranging in age from five to 40 days, at 5-day intervals. RP was recorded by measuring open circuit potential of RBCs using nanoporous gold electrodes with Ag/AgCl reference. RP measures were also performed on peripheral venous blood from 10 healthy volunteers. RP measures were compared between RBC groups, and with volunteer blood.

Direct measurement of RP was performed by measuring open circuit potential of the RBC sample via the np gold electrode, with Ag/AgCl reference, using a ParstatMC multi-potentiostat (Princeton Applied Research, Berwyn, PA, USA). The investigators reported that stored RBCs show time-dependent RP increases. There were significant differences in Day 5 RP compared to all other groups, Day 10–15 versus ages ≥ Day 20, Day 20–25 versus Day 40, and all groups compared to healthy volunteers. RP became more positive over time suggesting ongoing oxidation as RBCs age; however, storage time alone was not predictive of RP measured in a particular unit/segment.

The authors concluded that there were significant differences in RP between freshly stored RBCs and all others, with RP becoming more positive over time. However, storage time alone does not predict RP, indicating RP screening may be important independent of age and may serve as a marker of RBC health. Targeting RP may enable the use of antioxidant therapies to restore RP balance in stored RBCs, as well as systemically in those receiving multiple transfusions, improving the clinical effectiveness of RBCs and potentially reducing associated morbidities. The study was published on August 23, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
University of Michigan
Princeton Applied Research


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.